A detailed history of State Of Wisconsin Investment Board transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 1,198,429 shares of BMY stock, worth $61 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
1,198,429
Previous 1,188,234 0.86%
Holding current value
$61 Million
Previous $64.4 Million 22.76%
% of portfolio
0.14%
Previous 0.18%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $410,348 - $540,233
10,195 Added 0.86%
1,198,429 $49.8 Million
Q1 2024

May 14, 2024

SELL
$47.98 - $54.4 $515,689 - $584,691
-10,748 Reduced 0.9%
1,188,234 $64.4 Million
Q4 2023

Feb 12, 2024

BUY
$48.48 - $57.85 $1.13 Million - $1.34 Million
23,247 Added 1.98%
1,198,982 $61.5 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $126,258 - $141,176
-2,181 Reduced 0.19%
1,175,735 $68.2 Million
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $1.72 Million - $1.91 Million
-27,068 Reduced 2.25%
1,177,916 $75.3 Million
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $4.42 Million - $5.02 Million
67,292 Added 5.91%
1,204,984 $83.5 Million
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $5.8 Million - $6.86 Million
-84,659 Reduced 6.93%
1,137,692 $81.8 Million
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $43,736 - $25.9 Million
-336,434 Reduced 21.58%
1,222,351 $86.9 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $5.03 Million - $5.54 Million
-69,229 Reduced 4.25%
1,558,785 $120 Million
Q1 2022

May 13, 2022

BUY
$61.48 - $73.72 $8.96 Million - $10.7 Million
145,677 Added 9.83%
1,628,014 $119 Million
Q4 2021

Feb 11, 2022

SELL
$53.63 - $62.52 $18.3 Million - $21.3 Million
-341,370 Reduced 18.72%
1,482,337 $92.4 Million
Q3 2021

Nov 12, 2021

BUY
$59.17 - $69.31 $26.6 Million - $31.2 Million
450,391 Added 32.8%
1,823,707 $108 Million
Q2 2021

Aug 12, 2021

SELL
$61.91 - $67.42 $10.1 Million - $11 Million
-163,598 Reduced 10.64%
1,373,316 $91.8 Million
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $36.4 Million - $40.9 Million
-613,191 Reduced 28.52%
1,536,914 $97 Million
Q4 2020

Feb 03, 2021

SELL
$57.74 - $65.43 $35.2 Million - $39.9 Million
-610,014 Reduced 22.1%
2,150,105 $133 Million
Q3 2020

Nov 16, 2020

BUY
$57.43 - $63.64 $57.6 Million - $63.8 Million
1,002,520 Added 57.04%
2,760,119 $166 Million
Q2 2020

Aug 12, 2020

SELL
$54.82 - $64.09 $47 Million - $54.9 Million
-856,774 Reduced 32.77%
1,757,599 $103 Million
Q1 2020

May 06, 2020

BUY
$46.4 - $67.43 $6.61 Million - $9.6 Million
142,376 Added 5.76%
2,614,373 $146 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $13.7 Million - $17.9 Million
279,094 Added 12.73%
2,471,997 $159 Million
Q3 2019

Nov 12, 2019

BUY
$42.77 - $50.71 $3.83 Million - $4.54 Million
89,547 Added 4.26%
2,192,903 $111 Million
Q2 2019

Aug 14, 2019

SELL
$44.62 - $49.34 $2.65 Million - $2.93 Million
-59,395 Reduced 2.75%
2,103,356 $95.4 Million
Q1 2019

May 13, 2019

SELL
$45.12 - $53.8 $7.49 Million - $8.93 Million
-165,934 Reduced 7.13%
2,162,751 $103 Million
Q4 2018

Feb 11, 2019

BUY
$48.76 - $63.23 $2.34 Million - $3.03 Million
47,920 Added 2.1%
2,328,685 $121 Million
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $22.4 Million - $25.2 Million
405,541 Added 21.63%
2,280,765 $142 Million
Q2 2018

Aug 03, 2018

SELL
$50.53 - $62.98 $10.4 Million - $13 Million
-206,733 Reduced 9.93%
1,875,224 $104 Million
Q1 2018

May 07, 2018

SELL
$59.92 - $68.98 $9.7 Million - $11.2 Million
-161,916 Reduced 7.22%
2,081,957 $132 Million
Q4 2017

Feb 08, 2018

BUY
$59.94 - $65.35 $17.4 Million - $19 Million
290,622 Added 14.88%
2,243,873 $138 Million
Q3 2017

Nov 01, 2017

BUY
$55.23 - $63.74 $108 Million - $125 Million
1,953,251
1,953,251 $125 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $108B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.